Cen Biotech Inc's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of Cen Biotech Inc (CENB) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Peer Data As of Q3 2021
Competitors Tracked
-
Peer Group Market Share
100.00 %
Revenue Growth Y/Y
-
Net Margin
-264.15 %
Key Findings: Cen Biotech Inc vs Its Competitors
- TTM: Trailing 12-month revenue of 1M vs -M combined for tracked competitors (100.0% combined share).
- Trending: Latest-quarter revenue run-rate is decelerating (-20.7% annualized vs trailing 12 months).
- Peer revenue share: Cen Biotech Inc accounted for 100.0% of combined revenue among its tracked peer group.
Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).
CENB Sales vs. its Competitors, Q3 2021
Cen Biotech Inc generated 100.00 % of the combined sales of its peer group.
API endpoints for this dataset
https://api.csimarket.com/api/v1/companies/CENB/competitors
https://api.csimarket.com/api/v1/companies/CENB/relationships
https://api.csimarket.com/api/v1/companies/CENB/similar
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Connect Your AI Assistant
CENB Stock Performance relative to its Competitors
CENB
Competitors (weighted)
Percent change over the selected range
